Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jun
1
2023
This Week in 340B: May 23 – 30, 202 McDermott Will & Emery
May
31
2023
AAFCO Comments on the Pet Food Institute’s Proposed New Federalized Regulatory System for Pet Food Keller and Heckman LLP
May
31
2023
South Korea Looks to Tighten Biometrics Laws Amid Generative AI Squire Patton Boggs (US) LLP
May
31
2023
Majority of States Have Legalized Marijuana, but OSHA’s Post-Incident Drug-Testing Guidance Hasn’t Changed Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
May
30
2023
FDA Studies Foreshadow Potential Changes to Direct-to-Consumer Prescription Drug Advertising Nelson Mullins
May
30
2023
EPA Proposes Updates to TSCA New Chemicals Regulations; Comments Due July 25, 2023 Bergeson & Campbell, P.C.
May
30
2023
Trending in Telehealth: May 16 – 22, 2023 McDermott Will & Emery
May
29
2023
New Washington State Law Will Protect Job Applicants From Discrimination Based on Off-Duty Marijuana Use Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
May
28
2023
New Consumer Product Safety Regulations In The EU Barnes & Thornburg LLP
May
26
2023
ECHA Publishes Annual Report on Helpdesk Activities Bergeson & Campbell, P.C.
May
26
2023
China Proposes to Amend GB 4806.1 General Safety Standard for Food-Contact Materials Keller and Heckman LLP
May
26
2023
Analogous Art Must Be Compared to Challenged Patent McDermott Will & Emery
May
26
2023
Mcdermottplus Check-Up: May 26, 2023 McDermott Will & Emery
May
25
2023
Florida Bans Offshoring of Certain Patient Information Sheppard, Mullin, Richter & Hampton LLP
May
25
2023
Supreme Court Unanimously Affirms Amgen Repatha® Antibody Patents Invalid for Lack of Enablement Mintz
May
25
2023
Salmonella Outbreak Linked to Papa Murphy’s Cookie Dough Keller and Heckman LLP
May
25
2023
Minnesota Legislature Passes New Recreational Marijuana Bill Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
May
25
2023
EPA Will Propose Updates to New Chemicals Regulations to Improve Efficiency, Remove LVE and LoREX Exemptions for PFAS and Certain PBTs Bergeson & Campbell, P.C.
May
25
2023
FDA Establishes Public Docket Soliciting Comments on Nitrosamine Drug Substance-Related Impurities Nelson Mullins
May
25
2023
White House OSTP Extends Comment Period for RFI on NNI EHS Research Strategy Bergeson & Campbell, P.C.
May
24
2023
Implementation of FASTER Act Poses Challenge for Industry Keller and Heckman LLP
May
24
2023
Sequencing the Impact: How AI is Boosting Genomic Medicine Foley & Lardner LLP
May
24
2023
Mississippi Department of Health Revises Medical Cannabis Regulations: Feels Like I’ve Been Here Before Bradley Arant Boult Cummings LLP
May
23
2023
Registration Opens for NNI’s Second Webinar on U.S. Government Activities Addressing Micro- and Nanoplastic Issues Bergeson & Campbell, P.C.
May
23
2023
Marijuana in the Manufacturing Workplace Jackson Lewis P.C.
May
23
2023
More Federal Action in the Pharmaceutical Sector as PBM Bill Advances in the Senate Epstein Becker & Green, P.C.
May
22
2023
Supreme Court Voids Amgen’s Patents using “Undue Experimentation” Standard
May
19
2023
Supreme Court Delivers the Final Blow to Amgen Bradley Arant Boult Cummings LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins